Monday 4 October 2021

J&J Takes Lead in RSV Vaccine Race with 80% Efficacy in Phase II


J&J Takes Lead in RSV Vaccine Race with 80% Efficacy in Phase II: https://ift.tt/3mrp1En Read more... https://ift.tt/3oFCJWW

No comments:

Post a Comment